Abstract:Introduction Everolimus and sirolimus are immunosuppressants that inhibit mechanistic target of rapamycin (mTOR) used to prevent graft rejection after heart transplantation. Hypersensitivity pneumonitis is a known class effect toxicity of mTOR inhibitors. Prognosis is favorable if medication is stopped before there is extensive damage. We report two cases of hypersensitivity pneumonitis in patients receiving mTOR inhibitors. Case 1 A 45-year-old female who was 7 years S/P heart transplant for NICM presented to clinic for progressive shortness of breath for one month. Her post-transplant course was complicated by antibody-mediated rejection and allograft vasculopathy, for which mycophenolate mofetil (MMF) was substituted for everolimus 3months prior to her presentation. CT scan showed new ground glass opacities (GGO) throughout the right lung and the left lower lobe (figure 1a). An extensive infectious workup was negative. Bronchoscopy with BAL resulted in elevated polymorphonuclear leukocytes (55%), lymphocytes (4%), and macrophages (41%) with negative cultures and antigen testing. She remained hemodynamically stable on room air and was discharged on MMF instead of everolimus. After 2 months, her symptoms had improved, and repeat CT scan showed near complete resolution of prior infiltrates (Figure 1b). Case 2 A 41-year-old female who was 9 years S/P heart transplant for peripartum cardiomyopathy presented with 6 months of progressive shortness of breath and productive cough. MMF was switched to sirolimus for de novo donor-specific antibodies 6 months prior. On presentation, she was hemodynamically stable on room air. Labs were significant for WBC 20 x109/L with 48% eosinophils. CT scan showed patchy diffuse GGO (figure 2a). An extensive infectious workup was negative. Bronchoscopy with BAL showed 93% Eosinophils. The diagnosis of mTOR-induced eosinophilic pneumonitis was made, and sirolimus was stopped. She was discharged on a higher dose of MMF. Her symptoms continued to improve. Four months later, she had a repeat CT scan which showed resolution of GGO (figure 2b). Conclusion We present two cases of reversible mTOR inhibitor-induced hypersensitivity pneumonitis with full clinical and radiographic recovery with discontinuation of therapy. It is vital to screen for symptoms and recognize the diagnosis early as discontinuation of therapy can prevent significant morbidity. .

Sirolimus potentiated angioedema: A case report and review of the literature

Exemestane-Everolimus-Induced Angioedema in a Woman With Metastatic Breast Cancer: A Case Report and Review

Everolimus And Sirolimus Hypersensitivity Pneumonitis With Full Recovery: A Case Series

Use of sirolimus in solid organ transplantation

Sirolimus experience in adult patients with vascular malformations

Sirolimus experience in heart transplantation

The Double-Edged Sword of Immunosuppressive Therapy in Kidney Transplantation: A Rare Case Report of Pulmonary Mucormycosis Post-Transplant and Literature Review

A New Hypothesis Describing the Pathogenesis of Oral Mucosal Injury Associated with the Mammalian Target of Rapamycin (mTOR) Inhibitors

Sirolimus-eluting coronary stents: novel devices for the management of coronary artery disease

Everolimus-Induced Systemic Serositis After Simultaneous Liver and Kidney Transplantation: A Case Report

Sirolimus combined with glucocorticoids in the treatment of Kasabach-Merritt phenomenon in a neonate: A case report

Prospective Observational Study of Sirolimus As Primary Immunosuppression after Renal Transplantation

A Case Report of 2 Sirolimus-Related Deaths among Infants with Kaposiform Hemangioendotheliomas

Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection

Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patients

Ultrasound-targeted Sirolimus-Loaded Microbubbles Improves Acute Rejection of Heart Transplantation in Rats by Inhibiting TGF-β1-Smad Signaling Pathway, Promoting Autophagy and Reducing Inflammation

Wound Healing Complications and the Use of Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation

Topical sirolimus in dermatology: a systematic review

Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature.

S4910 Gastroenterologist's Recognition of Rare Adverse Drug Effect Prevents Further Harm in a Patient with Small Bowel Obstruction Due to Lisinopril: A Case Report and Literature Review

Successful Treatment of Postmenopausal Exacerbation of Abdominal Lymphangioleiomyomatosis With Sirolimus: A Report of a Rare Case